US Patent Issued to YEP BIO on March 3 for "Pharmaceutical composition for preventing or treating parkinson's disease, comprising 2-(4-(1-hydroxypropane-2-yl)phenyl)isoindoline-1-one compound" (South Korean Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,574, issued on March 3, was assigned to YEP BIO Co. LTD. (Anyang-si, South Korea).

"Pharmaceutical composition for preventing or treating parkinson's disease, comprising 2-(4-(1-hydroxypropane-2-yl)phenyl)isoindoline-1-one compound" was invented by Chi Hu Park (Hwaseong-si, South Korea), Myungjoo Yu (Seoul, South Korea) and Hyoung Shik Kim (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for preventing or treating Parkinson's disease, comprising a 2-(4-(1-hydroxypropane-2-yl)phenyl) isoindoline-1-one compound or a pharmaceutically acceptable salt thereof, wherein t...